Accessia Health

Overview

Accessia Health is the current operating name for Patient Services Inc. (PSI), rebranded as Accessia Health to reflect a broader, person-centered assistance mission. Buyers searching Patient Services Inc., PSI, or the legacy charitable patient assistance brand should evaluate Accessia as the active foundation. Its role is different from a manufacturer copay-card vendor: Accessia administers charitable assistance through disease-specific programs, with support that can include medication copays or coinsurance, health insurance premiums, travel, medical expenses, education, case management, and legal aid for disability benefits.

For a biopharma launch team, Accessia is most relevant when a therapy area has patients facing broader financial and access barriers than medication cost alone. Its “Your Assistance. Your Choice.” model emphasizes flexible use of assistance across copays, premiums, travel, and medical expenses. Manufacturer diligence should focus on compliant donor relationships, disease-fund availability, patient eligibility, aggregate reporting, independence safeguards, and how provider or patient workflows connect into Accessia’s programs.

Affordability Capability Model

The framework below standardizes how Rx Almanac evaluates copay-financial-assistance capabilities, so buyers can compare vendors like-for-like while the readout column stays vendor-specific. For this table, Accessia Health is evaluated as an independent charitable patient-assistance foundation and the active operating name for Patient Services Inc. (PSI).

Capability	Buyer should compare	Accessia Health readout
Copay card design and claims adjudication	Program setup, BIN/PCN/group logic, real-time pharmacy adjudication, benefit limits, reversals, and claims reconciliation.	Core affordability operations. Public provider resources describe assistance with copay or coinsurance for eligible insured patients.
PAP, foundation, and free-drug support	Eligibility screening, income verification, foundation routing, free-drug workflows, renewals, and bridge program administration.	Core affordability operations. Accessia is a charitable patient assistance organization, not a brand-controlled copay-card administrator. Differentiated. The flexible-assistance model spans travel, medical expenses, insurance premiums, and medication copays.
Accumulator, maximizer, and affordability controls	Detection and mitigation of accumulator/maximizer exposure, plan edits, alternative funding, and program rule tuning.	Not the main buying reason for Accessia Health; validate only if the SOW includes accumulator, maximizer, and affordability controls.
Eligibility, enrollment, and patient communications	Digital enrollment, status updates, patient support, card activation, reminders, and multilingual service workflows.	Case-management model. Accessia positions its model around personalized case management, education, and person-centered support. Documented differentiator. The A.C.C.E.S.S. legal aid program supports disability-benefit claims.
Payment rails, debit/card, and pharmacy integration	Card issuing, debit rails, reimbursement, pharmacy switch connectivity, payment settlement, and vendor integrations.	Not the main buying reason for Accessia Health; validate only if the SOW includes payment rails, debit/card, and pharmacy integration.
Compliance, reporting, and GTN visibility	Program controls, audit trails, utilization reports, budget visibility, GTN impact, and manufacturer dashboards.	RFP-critical. Buyers should review the patient assistance code of conduct, fund rules, reporting limits, and compliance governance before donating.

Buyer Fit

• Use-case fit: Evaluate Accessia when a disease area needs independent foundation support for patients whose barriers include premiums, travel, diagnostics, medical expenses, or disability-benefit navigation.
• Not the right fit: Do not use Accessia as a substitute for a manufacturer copay-card vendor, debit-card program, pharmacy-switch adjudication partner, or brand-directed affordability platform.
• Launch fit: Strongest when rare or chronic disease patients face substantial non-medication costs and when compliant charitable support can complement hub, field reimbursement, and patient-services programs.
• Provider fit: Provider offices can use Accessia resources to help patients screen and apply for assistance.
• Manufacturer diligence: Confirm open funds, disease definitions, contribution rules, reporting cadence, independence safeguards, privacy boundaries, and how Accessia communicates fund availability.

Differentiators

• Holistic assistance model: Accessia supports more than copays, including premiums, travel, medical expenses, case management, education, and legal aid.
• Flexible assistance categories: The “Your Assistance. Your Choice.” model lets eligible patients allocate assistance across multiple need categories within program rules.
• Rare and chronic disease orientation: More than 90 disease-specific programs give Accessia breadth across specialty-heavy conditions.
• Legal aid adjacency: A.C.C.E.S.S. gives the foundation a disability-benefits support lane that most pure affordability vendors do not offer.
• Patient and medical advisory structure: The 2025 Patient Advocacy Committee and Medical Advisory Council activity strengthens the person-centered governance story.

RFP Questions

• Which disease funds are open, waitlisted, or closed for the target condition?
• What assistance categories are available for the disease fund, and what limits apply to each category?
• How are eligibility, documentation, renewal, and appeal workflows handled for patients and providers?
• What donor contribution rules, independence safeguards, and anti-kickback controls govern the fund?
• What aggregate reporting can a manufacturer receive without compromising patient privacy or charitable independence?
• How does Accessia coordinate with hub services, specialty pharmacies, advocacy organizations, and provider offices?
• What patient communication, case management, education, and legal-aid workflows are included?

Recent Activity

• 2026: Accessia’s public flexible-assistance materials emphasize patient choice across medication copays, premiums, travel, and medical expenses.
• In September 2025, Accessia announced Alan Wood as EVP of Development and Growth, James P. Johnson as EVP of Operations, a relaunched Patient Advocacy Committee, and a new Medical Advisory Council.
• 2026: Public Accessia materials and partner profiles continue to frame the organization around rare and chronic disease patients, provider-facing application support, and broad non-medication expense barriers.